![Ivacaftor / Phenols / Quinolones / Cystic fibrosis transmembrane conductance regulator / Cystic fibrosis / Vertex Pharmaceuticals / Ion channel / CFTR / Cystic Fibrosis Foundation / Biology / Health / Anilides Ivacaftor / Phenols / Quinolones / Cystic fibrosis transmembrane conductance regulator / Cystic fibrosis / Vertex Pharmaceuticals / Ion channel / CFTR / Cystic Fibrosis Foundation / Biology / Health / Anilides](https://www.pdfsearch.io/img/60fdec1fb4ba4218a6b176d4300173ec.jpg)
| Open Document File Size: 3,34 MBShare Result on Facebook
City Bethesda / Boston / / Company Vertex Pharmaceuticals / Development Vertex Pharmaceuticals Incorporated / / Country United States / / Event Product Issues / / Facility Duke University / Robert Temple / / MedicalCondition Genetic Disease / Disease / CF Disease / *cystic fibrosis / Acceptable benefit/risk profile Cystic Fibrosis / / NaturalFeature Defect Low Chloride Flow CFTR channel / / Organization Duke University / FDA / / Person Van Goor / Janet Woodcock / Andrew Mulberg / David Goldstein / Anthony Durmowicz / Jeffrey Chodakewitz / Marshall Summar / Mike Pacanowski / Ivacaftor Jeffrey Chodakewitz / Jeffrey A Chodakewitz / / Position Head / / Product CFTR* channel function / processing / / ProvinceOrState Maryland / / RadioStation CFTR / / Technology drug development / /
SocialTag |